Low-dose Naltrexone Targets the Opioid Growth Factor-Opioid Growth Factor Receptor Pathway to Inhibit Cell Proliferation: Mechanistic Evidence From a Tissue

Exp Biol Med (Maywood)
September 2011
https://pubmed.ncbi.nlm.nih.gov/21807817/

Naltrexone and Dysphoria: Fact or Myth?

Am J Addict
Spring 2002
https://pubmed.ncbi.nlm.nih.gov/12028745/

Adding ultralow-dose naltrexone to oxycodone enhances and prolongs analgesia: a randomized, controlled trial of Oxytrex

J Pain
June 2005
https://pubmed.ncbi.nlm.nih.gov/15943961/

Off-label, Low-Dose Naltrexone for Refractory Chronic Low Back Pain

Pain Med
May 2014
https://europepmc.org/article/med/24967470

Low-dose naltrexone inhibits the epithelial-mesenchymal transition of cervical cancer cells in vitro and effects indirectly on tumor-associated macrophages in vivo

Int Immunopharmacol
September 2020
https://pubmed.ncbi.nlm.nih.gov/32585612/

Ameliorative response to detoxification, psychotherapy, and medical management in patients maintained on opioids for pain

Am J Addict
Oct 2017
https://pubmed.ncbi.nlm.nih.gov/28800186/

Biased Opioid Antagonists as Modulators of Opioid Dependence: Opportunities to Improve Pain Therapy and Opioid Use Management  (Abstract)

Molecules
11 Sept 2020
https://pubmed.ncbi.nlm.nih.gov/32932935/

Intranasal Low-Dose Naltrexone Against Opioid Side Effects: A Preclinical Study (Abstract)

Front Pharmacol
18 Sept 2020
https://pubmed.ncbi.nlm.nih.gov/33071790/

Abuse Liability, Anti-Nociceptive, and Discriminative Stimulus Properties of IBNtxA (Abstract)

ACS Pharmacol Transl Sci
27 July 2020
https://pubmed.ncbi.nlm.nih.gov/33073190/

Low-Dose Naltrexone: An Inexpensive Medicine for Many Ills?

Medscape Medical News
11 Mar 2020
https://www.medscape.com/viewarticle/926611?src=WNL_trdalrt_201027_MSCPEDIT&uac=267476HJ&impID=2640101&f

Subscribe to Opiod